Grauer & Weil India growth over the years

Compounded a year1 yr3 yr
Revenue+4.5%+6.5%
EBITDA+4.4%+8.5%
Net Income+6.5%+14.3%
EPS (adj.)+6.5%+14.3%
Total Assets+12.5%+14.8%
Free Cash Flow+2.6%+1.9%
Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

GRAUWEIL₹82.12

Grauer & Weil India Limited

· Chemicals
₹ CrorePeersAMALARCLCHEMCRUXDAICHIELANTASINDOKEMJYOTIRESKANCHIMcap ₹3,722 Cr
Annuals · FY-end closes
Compounded Growth
Annuals · CAGR %
1Y
CAGR
3Y
CAGR
Revenue+4.5+6.5
EBITDA+4.4+8.5
Net Income+6.5+14.3
EPS (adj.)+6.5+14.3
Total Assets+12.5+14.8
Free Cash Flow+2.6+1.9
CAGR from filed annuals — needs positive start & end values.
« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 85%.